| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Wesana Health Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.0025 |
| 52 Week High | CA$0.048 |
| 52 Week Low | CA$0.001 |
| Beta | -0.40 |
| 11 Month Change | 0% |
| 3 Month Change | -50.00% |
| 1 Year Change | -94.19% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -99.71% |
Recent News & Updates
Recent updates
Shareholder Returns
| DDX | DE Pharmaceuticals | DE Market | |
|---|---|---|---|
| 7D | -28.6% | -5.6% | -0.1% |
| 1Y | -94.2% | -18.5% | 2.3% |
Return vs Industry: DDX underperformed the German Pharmaceuticals industry which returned -18.5% over the past year.
Return vs Market: DDX underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| DDX volatility | |
|---|---|
| DDX Average Weekly Movement | 253.4% |
| Pharmaceuticals Industry Average Movement | 5.7% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.3% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: DDX's share price has been volatile over the past 3 months.
Volatility Over Time: DDX's weekly volatility has increased from 175% to 255% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Daniel Carcillo | www.wesanahealth.com |
Wesana Health Holdings Inc. does not have significant operations. Previously, it was developing evidence-based formulations and protocols that empower patients to overcome neurological, psychological, and mental health ailments caused by trauma. The company is headquartered in Chicago, Illinois.
Wesana Health Holdings Inc. Fundamentals Summary
| DDX fundamental statistics | |
|---|---|
| Market cap | €355.44k |
| Earnings (TTM) | -€1.70m |
| Revenue (TTM) | n/a |
0.0x
P/S Ratio-0.2x
P/E RatioIs DDX overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| DDX income statement (TTM) | |
|---|---|
| Revenue | US$0 |
| Cost of Revenue | US$0 |
| Gross Profit | US$0 |
| Other Expenses | US$1.83m |
| Earnings | -US$1.83m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.052 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | -60.7% |
How did DDX perform over the long term?
See historical performance and comparison